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INTRODUCTION
Since their initial discovery in 1981, mouse embryonic stem cells have allowed
research on regenerative medicine to progress greatly in a little over three decades
(Evans, 1981; Martin, 1981). These embryo-derived pluripotential cells have the ability
to retain a normal karyotype when cultured in vitro, and possess a highly differentiative
potential (Bradley, 1984). In addition, mouse embryonic stem cells have the ability to
develop into a wide range of adult tissues, providing a leeway for introducing genetic
changes to its genome (Thomson, 1998).
In addition, an emerging technology known as three-dimensional (3D) tissue
engineering has allowed scientists to mimic tissues found in vivo. Previous studies
indicate that it is possible to differentiate dissociated mouse embryonic stem cells
(mESCs) into 3D retinal tissues in vitro (Bertacchi, 2015; Eiraku, 2012). The newly
differentiated retinal tissues are said to encompass all of the major components found in
retinal tissues. Prior to this, it was only possible to differentiate mESCs into twodimensional retinas in a culture dish; however, the differentiation into 3D retinas are
more beneficial in research, as the 3D retinal culture allows us to visualize tissue
morphology as well as cell-cell interactions (Ravi, 2014).
The generation of in vitro 3D tissues holds great potential in terms of patientspecific disease modeling. Although various diseases have been well-studied in animal
models, there are limitations with regards to patient-specificity. For example, there are
presently a total of 49 mutations in the human gene Cone-Rod Homeobox (Crx) that have
been linked to various retinal degenerative diseases such as Leber Congenital Amaurosis,
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Cone-Rod Dystrophy, and Retinitis Pigmentosa (Huang, 2000). The generation of animal
models to study each specific mutation would be impractical and costly. With in vitro
generation of tissues and organs, scientists have the capacity to generate disease models
consisting of mutations specific to patients. The generation of 3D disease models would
also allow scientists to pinpoint the molecular pathways associated with each mutation,
which could potentially result in more personalized treatments for patients.
There are various gene editing techniques available to generate and recreate
disease-specific 3D disease models using stem cells. The newest gene editing technique
known as Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR) has
allowed scientists to edit the genome with greater precision than other genome editing
technologies like Zinc Finger Nucleases (ZFNs) or Transcription Activator-like Effector
Nucleases (TALENs). The CRISPR-Cas9 system was initially adapted from bacteria and
archaea, in which it is used as a defense mechanism to fight foreign invaders such as
phages (Segal, 2015). With genome engineering, the CRISPR-Cas9 complex consists of a
helicase, nuclease, and a target-specific guide RNA (gRNA) which all work together to
perform disease-specific gene editing.
In order to overcome current limitations on disease-specific model systems, we
developed a protocol for differentiating mouse embryonic stem cells into 3D retinas in
vitro. In addition, to confirm the utility of this 3D model for future disease-specific
mutations, we utilized the CRISPR method as a means to knockdown the transcription
factor CRX, which is known to regulate key developmental decisions during
retinogenesis, and as such, mutations in CRX have resulted in various diseases such as
Leber Congenital Amaurosis, Cone-Rod Dystrophy, and Retinitis Pigmentosa.
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The specific aims for this study are as follows:
1. To develop a protocol for differentiating mouse embryonic stem cells into threedimensional retinas in vitro.
2. To confirm the critical role of key transcription factor, Cone Rod Homeobox
(Crx), during three-dimensional retinal development in vitro following Clustered
Regularly Interspersed Short Palindromic Repeat (CRISPR) knockdown.
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BACKGROUND
1. Anatomy and Physiology of the Retina
The retina lines the posterior portion of the eye. It is responsible for responding to
incoming light and jump-starting the early stages of image processing. The retina is made
up of four main layers: the ganglion cell layer (GCL), inner nuclear layer (INL), outer
nuclear layer (ONL), and the retinal pigment epithelium (RPE) (Figure 1). In addition,
there are eight main cell types present in the retina. These include retinal ganglion cells,
Müller glia, bipolar and horizontal interneurons, amacrine, rod and cone photoreceptors,
and retinal pigment epithelial cells. The intricate physiology of retinal components shows
how they work together to allow us to visualize the world around us clearly and
efficiently.

Figure 1: Overview of the Retina. The retina lines the posterior of the eye. A zoomed in region of the retina shows the
various cellular bodies. The retina consists of four major layers: Ganglion Cell Layer (GCL), the Inner Nuclear Layer
(INL), Outer Nuclear Layer (ONL), and Retinal Pigment Epithelium Layer (RPE). The GCL consists of ganglion cells
as well as the optic nerve, which travels to the visual cortex of the forebrain. The INL consists of amacrine, bipolar and
horizontal cells. The ONL consist of rod and cone photoreceptor cells. The RPE layer consists of RPE cells. The
choroid, located directly behind the RPE, is the main source of blood supply to the retina.

The ganglion cell layer (GCL) is where cells collect visual information from

4

amacrine and bipolar cells. The GCL is where all of the chemical signals are transformed
into electrical signals, which are then transmitted into the optic nerve and the brain
Tanaka, 2015). The nerve fiber layer (NFL) is made up of ganglion cells with fibers that
connects to the brain (Kaplan, 2001). All information from the GCL travels through the
NFL and into the visual cortex of the brain, which is the final visual assembly point.
The inner nuclear layer (INL) consists of horizontal, bipolar, amacrine, and
interplexiform cells. Horizontal cells are flatter with dendrites dividing into several
branches in the outer plexiform layer. What distinguishes horizontal cells from the rest
of the cells in the retina is that their axons run horizontally. The job for bipolar cells is to
receive input from photoreceptor cells (Bloomfield, 2001). Amacrine cells contain
neurotransmitters and receive input from the bipolar cells (Farsaii, 2011).
The outer nuclear layer (ONL) contains the cell bodies of rod and cone
photoreceptor cells. Rod cell bodies are spherical, more abundant, and dispersed to
different layers throughout the ONL (Bloomfield, 2001). The cone cell bodies, however,
are stem-like and are mostly located closer to the center of the retina (Purves, 2001). The
layer of neuronal synapses is embedded in the outer plexiform layer, where the axons of
horizontal and bipolar cells meet the axons of photoreceptor cells (Yau, 1994). Here, the
visual signal is split depending on information received from rod and cone cells. The
outer plexiform layer detects and focuses objects either lighter than the background, or
darker than the background.
The photoreceptor cells are collectively responsible for absorbing and responding
to any light that reaches the eye. Cone cells are responsible for responding to higher
wavelengths of light and processing colors (Bowmaker, 1979). They are mostly found in
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the central fovea. Rod cells are more abundant than cone cells, accounting for 95% of all
photoreceptor cells in the retina (Kaewkhaw, 2015). Rod cells respond to changes in light
intensities and absorb black, gray, and white light (Bowmaker, 1979). The loss of rod
cells light absorption and therefore results in blindness.
The retinal pigmented epithelium (RPE) layer is involved in light absorption,
epithelial transport, spatial ion buffering, the visual cycle, phagocytosis, and immune
modulation (Strauss, 2005). Any light not absorbed by photoreceptor cells gets absorbed
by the formation of a dark pigmented wall in the inner bulbs of the RPE for further image
processing (Beatty, 2000). This process also helps to prevent the scattering of light,
which can result in the obstruction of clear vision. Water is produced in large quantities
in the retina due to an abundance of neurons and photoreceptors and intraocular pressure
(Strauss, 2005). While water in the inner retina is removed via Müller glia (MG), all
water present in the sub retinal space is removed through epithelial transport in the RPE
(Alm, 1973). The RPE is also involved in the transportation and distribution of glucose
and other nutrients from the blood stream, and retinol to photoreceptors. Spatial ion
buffering compensates for rapid changes in ion concentration in the RPE. Because
photoreceptors are constantly exposed to intense levels of light, they need to constantly
replenish themselves. All waste accumulated through the replenishment process is
phagocytosed in the RPE (Strauss, 2005). Finally, the RPE is in charge of secreting a
variety of growth factors and other essential nutrients that are useful in the maintenance
and structure of the retina.
The choroid layer lines the outermost segment of the retina. This layer consists of
a series of blood vessels and connective tissue. Traditionally, the main function of the
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choroid was to provide the outer retina with oxygen and nutrients. However, recent
studies suggest the choroid may also be responsible for thermoregulation, adjustment of
retinal position, and secretion of retinal growth factors (Anand-Apte, 2010).
2. Cone-Rod Homeobox (Crx)
The Cone-Rod Homeobox (Crx) gene lies downstream from the transactivator gene
Orthodenticle Homeobox 2 (Otx2), which is required for assisting in the production of
photoreceptor cells (Chen, 1997; Kimura, 2000). Crx is a structural gene that encodes a
transcription factor (CRX) expressed during early retinal cell development and in
newborn photoreceptor cells. CRX interacts with other transcription factors including
NRL, RORB, and RAX to regulate transcription of photoreceptor cells (Kimura, 2000).
The Crx gene is located on chromosome 7 in the mouse (Mus musculus) and consists of
14,009 base pairs (Figure 2). There is a total of two known splice variants of Crx, both
containing four exons.

Figure 2: Outline of Cone-Rod Homeobox (Crx) in Mus musculus. The Crx gene is located on chromosome
7, totaling 14,009 base-pairs in length. The gene contains four exons, with the fourth exon being the
longest.
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Normal CRX function is necessary for the maintenance of cone and rod
photoreceptors. Mutations in Crx result in photoreceptor cell degenerative diseases
including Cone-rod dystrophy, Leber congenital amaurosis, and in some cases retinitis
pigmentosa (Huang, 2000, Decembrini, 2014). A previous study has shown that a
complete absence of CRX led to defects in the development of photoreceptors (Ohsawa,
2007). A complete Crx knockout in animal models have also been linked to retinal
degeneration. CRX-deficient mice also fail to produce the outer segments of the
photoreceptor layer and therefore lack proper maturation of rod and cone photoreceptor

Figure 3: Crxtvrm65 Mice Exhibit Lack of Production of Crx Protein, as well as Mature Photoreceptors at Postnatal 5
Weeks. (A’-A’’’) Presence of Crx protein, as well as abundant presence of Otx2, a cofactor for Crx located upstream of
the gene. (B’-B’’’) Lack of production of Crx protein as well as rod cell opsin protein, Ret-P1, in Crxtvrm65 mice at 5
weeks. Otx2 expression remains consistent between both control and Crxtvrm65.

cells (Furukawa, 1999). Although no obvious morphological differences can be discerned
between young CRX homozygous and CRX-deficient mice, one-month-old CRXdeficient mice display less than 1% of normal rod activity and a 90% reduction of cone
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function (Furukawa, 1999).
In the lab, we have generated a Crx mutant Mus musculus animal model exhibiting
retinal degeneration due to a single nucleotide mutation (Crxtvrm65). Figures 3 and 4 below
demonstrate the retinal degeneration in a 5-week-old mouse retina compared to control
mouse retina. It has been shown that photoreceptor cells form in Crx mutant mice;

Figure 4: Crxtvrm65 Mice Exhibit degradation of Photoreceptor Cells at Postnatal 5 Weeks. (A’-A’’’) Control mice show
proper lamination of Blue Cone Opsin (BCO), as well as pan-photoreceptor protein Recoverin at postnatal 5 weeks.
(B’-B’’’) Crxtvrm65 mice, however, show degradation of both BCO and Recoverin as they both lack proper lamination.
(A and B) The yellow bars indicate degeneration of photoreceptor layer. DAPI stains nuclei. Scale bars 100µm.

however, the lack of proper function of the gene results in either hindered maturation of
photoreceptors or

degeneration of photoreceptor cells. Figure 3 shows a comparison between a control
mouse retina and a Crx mutant mouse retina at 5 weeks postnatal. At 5 weeks, Crx
mutant mice exhibited no production of the Crx protein (Fig 3B’) or the rod cell opsin
protein, Ret-P1 (Fig 3B’’). Protein expression of Otx2, being upstream of Crx, remained
constant in both the control and knockout mouse model (Fig3B’’). There were also signs
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of degeneration of photoreceptor cells in general in the Crx mutant compared to control
(Figure 4). Compared to of control (Fig4A’), there was a loss of proper lamination of
Blue Cone Opsin (BCO) and the pan-photoreceptor protein Recoverin in the Crx mutant
mice at 5 weeks (Fig 4B’). There was also reduction in size of the photoreceptor layer in
Crx mutant mice, as shown by the yellow bar (Fig 4A and 4B). The Crx mutant mouse
models show that there are instances where photoreceptor cells are produced in the
absence of Crx, however, Crx is still necessary for the proper functioning and
maintenance of photoreceptor cells.
3. Traditional Mouse Embryonic Stem Cell Culture and Maintenance
Mouse embryonic stem (ES) cells are found in the inner mass of the mouse
blastocyst. When isolated and cultured ex vivo, ES cells have the ability to remain
pluripotent, which allows ES cells to become any cell type (Bradley, 1984). In addition to
their ability to remain pluripotent, ES cells are able to retain a normal diploid karyotype
even after 140 cycles of division (Bertacchi 2015; Eiraku, 2012).
Mouse ES cells are traditionally cultured in vitro using culture dishes coated with
solubilized basement membrane and maintained using stem cell growth medium
containing fetal bovine serum (FBS) and leukemia inhibitory factor (LIF). They can
remain undifferentiated by inhibiting the glycogen synthase kinase 3 pathway as well as
the mitogen-activated protein kinase pathway. ES cells can also be prevented from over
proliferating by passaging upon reaching approximately 70% confluency. Passaging
requires the cells to be dissociated from their colonies using a protease solution, such as
accutase, trypsin, or papain. Following dissociation, the cells are collected and
resuspended in a new culture plate coated with solubilized basement membrane and
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growth medium.
4. Three-Dimensional Tissue Engineering
Since the emergence of in vitro eukaryotic cell culture approximately 40 years ago,
scientists have relied on glass or polystyrene coated dishes for culturing cells and tissues
(Freshney, 2005) to allow cells to adhere and grow in two dimensions. Although twodimensional tissue cultures continue to be used for most studies within basic research
labs, such cultures are proving to be unreliable for studies involving translational research
and regenerative medicine (Decembrini, 2014). For example, two-dimensional cell
cultures fail to mimic the extracellular environment found in native tissues which hinders
the ability of scientists to accurately measure gene expression, cellular migration, and
apoptosis found in vivo (Haycock, 2010). The emergence of three-dimensional tissue
engineering has provided a more direct link between in vitro studies and their translation
into clinical settings. With the use of appropriate biocompatible scaffolds such as
polymers, stem cells can be used to form any three-dimensional tissue, mimicking in vivo
developmental processes (Haycock, 2010).
In terms of in vitro retinal development, three dimensional retinal organoids have
opened new gateways in terms of replacement therapies (Eiraku, 2011; Ali, 2011). Due to
the diverse population of cells located in the retina, it is important to have the ability to
obtain the most homogenous population of cells for in vivo transplantation (Eiraku,
2011). In previous studies, researchers found that it is possible to generate photoreceptor
cells in a two-dimensional culture system and have some integration when transplanted
into the mouse retina (Lamba, 2009; West, 2012). However, the embryonic
developmental process of photoreceptors is more closely mimicked in a three11

dimensional retinal organoid than a two-dimensional culture system. A previous study
has shown that the production of correctly staged photoreceptors in 3D retinal organoids
allowed for better cell integration following transplantation (Gonzales-Cordero, 2013).
Studies conducted thus far have indicated the benefits of three-dimensional organoids
over two-dimensional culture systems, and show their usefulness in regenerative
medicine.
5. Genome Engineering
The notion of altering genes to study and treat diseases has been around since the
early 1970s (Jaenisch, 1974). The first transgenic mouse using viral DNA was created in
1974, and this was followed by the introduction of knock-out mice a few years later
(Smithies, 1985; Robertson, 1986). Retroviral gene therapy for treating patients with life
threatening genetic disorders developed in the 1990s when doctors administered a
retrovirus-driven gene therapy to a patient with Severe Combined Immunodeficiency
(SCID). The patient showed a temporary response to the treatment, initiating an influx of
donors for more gene therapy-based clinical trials (Tobita, 2015). Unfortunately, the
development of a leukemia-like phenotype in a patient undergoing gene therapy caused a
suspension of clinical trials around the world (Check, 2002). Although retroviral therapy
was not as successful as originally anticipated, it did initiate a cascade of advancements
with regards to structured genome engineering techniques. This began with the
introduction of zinc finger nucleases (ZFN), followed by a more complex engineering
system known as Transcription Activator-like Effectors (TALEs), and most recently the
adaptation of Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR).
Zinc finger nucleases (ZFNs) were one of the first widely used genome engineering
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tools (Miller, 1985). These custom designed nucleases are made by combining a DNAbinding domain with a DNA-cleavage domain (Smithies, 1985). ZFNs are able to
recognize a total of 9 to 18 nucleotides, and the cleavage domain induces a doublestranded break in the target sequence. The natural repair machinery of the cell then
allows an insertion via introduction of a desired DNA sequence, or deletion of the target
sequence. The main limitation of ZFNs was in their construction. There are two publicly
available methods to create specialized zinc-finger proteins, including the modular
assembly and the combined Oligomerized Pool Engineering (OPEN) and Contextdependent Assembly (CoDA), or OPEN/CoDA (Segal, 2015). Modular assembly joins
specially designed fingers that can recognize a specific 3-base pair sequence. The
downfall to modular assembly is that the highly specific designs of these fingers were
resulting in a reduced activity of the three-finger arrays (Segal, 2015). After discovering
this pitfall with modular assembly derived fingers, scientists moved towards a more
revolutionary zinc-finger protein designing tool, known as OPEN/CoDA. With
OPEN/CoDA, a wide variety of fingers are designed to accommodate not only the final
binding site, but also the fingers neighboring the final binding site (Segal, 2015).
The TALE DNA binding sequence was discovered in 2009, which prompted the
engineering of TALE proteins for genome modifications (Boch, 2009). Naturally
occurring TALE proteins are found in the bacterial genera Xanthomonas and Ralstonia,
where the proteins assist in the infection of plants (Boch, 2010). The highly-conserved
nature of TALE proteins allowed it to be the ideal choice in terms of personalized
genome engineering nucleases. The DNA-recognition elements of TALE proteins consist
of a series of tandem repeats equaling approximately 34 amino acids (Segal, 2013). In
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addition, each TALE repeat can recognize a single DNA nucleotide.
While scientists were utilizing this newer, better alternative tool for genome
engineering, another more robust genome engineering tool emerged. The gene editing
technique known as Clustered Regularly Interspaced Short Palindromic Repeats
(CRISPR) is a naturally occurring mechanism in bacteria and archaea that is used as a
defense mechanism against phages (Barrangou, 2007). The short palindromic repeats of

Figure 5: Overview of the Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR) Mechanism. The
Cas9 endonuclease encompasses the gRNA, which directs it to the target site on the genomic DNA, which is followed by
the protospacer adjacent motif (PAM). Following location of the target site, the endonuclease induces a double
stranded break in the DNA, in which the DNA’s natural repair machinery reanneals the two broken ends.

DNA are approximately 20-40 base pairs in length which form hairpins during
transcription. These repeats act as spacers for foreign viral DNA recognition sequences
(Barrangou, 2007). Each palindromic sequence is separated from another palindromic
sequence by a protospacer. Each protospacer DNA sequence is unique. In the early
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2000s, scientists found that these protospacer DNA segments aligned perfectly with viral
DNA (Bolotin, 2005). In addition, preceding these short palindromic repeats are helicase
and nuclease genes known collectively as Cas genes.
In the presence of any foreign DNA sequence (as might be found in a phage), the
CRISPR-Cas system responds by releasing a Cas protein complex containing a segment
of CRISPR-RNA (crRNA), which includes the protospacer elements (Barrangou, 2014).
After being guided to the target site, the Cas protein can cleave and destroy the foreign
piece of DNA. If a pathogen injects a foreign DNA sequence not previously recognized
by CRISPR, a class of Cas proteins known as Class I Cas proteins are released which
bind to this foreign DNA strand. Before it is cleaved by the nucleases, a segment of the
foreign gene is added to the palindromic repeats as a spacer.
In terms of gene editing, an RNA sequence known as the single guide RNA, or
sgRNA, guides the Cas9 endonuclease to its locus of interest where the endonuclease
creates a double stranded break (Figure 5). The sgRNA is made up of CRISPR-RNA
(crRNA) and the transactivating RNA (trRNA). The crRNA consists of a 20-base pair
protospacer element that is complementary to the target region of the gene to be edited
(Barrangou, 2014). The trRNA is the segment of the sgRNA that guides the Cas9
endonuclease to its cleavage site. The three main functions of the Cas9 endonuclease are:
(1) to bind to the sgRNA; (2) to bind to the target DNA; and (3) to cleave the target
DNA, resulting in a double-stranded break.
Two repair mechanisms that cleaved DNA sequences can undergo include the nonhomologous end-joining (NHEJ) mechanism and the homologous directed repair (HDR)
mechanism. The NHEJ mechanism is employed if there are no DNA repair templates
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provided with the CRISPR complex (Capecchi, 2005). As a result, the NHEJ mechanism
is more error prone, resulting in random mutations. The HDR mechanism is much
preferred due to the presence of a repair template that specifies modifications that need to
be made on the DNA template. The HDR repair mechanism is more widely preferred for
creating point mutations or inserting a gene of interest due to the repair template being
provided for the repair of the double-stranded break.

16

MATERIALS AND METHODS
1. Culture of Mouse Embryonic Stem Cells
Mouse embryonic stem cells (mESC) were cultured on Matrigel- coated plates
using mouse embryonic stem cell (MESC) media containing Dulbecco's Modified Eagle
Medium Nutrient Mixture F-12 (DMEM-F12), fetal bovine serum (FBS), non-essential
amino acids, 0.1M β-mercaptoethanol, and penicillin/streptomycin. CHIR99021 and
PD0325901 were also added to enhance mESC self-renewal. To allow the stem cells to
remain in their undifferentiated state, we used leukaemia inhibitory factor (LIF).
To avoid stem cell crowding and death, the cells were split upon reaching
approximately 90% confluency. The cells were washed once with phosphate buffered
saline (PBS; Corning, Corning, NY) to rinse off residual MESC media. The cells were
then dissociated using 1X trypsin (Corning). Following dissociation, the trypsin was
neutralized using FBS containing media, and the cells were transferred to a 15mL conical
tube (Gene Mate, Kaysville, UT). The cells were centrifuged at 270xg for 3 minutes.
Following centrifugation, the media was removed, and the cells were resuspended using
fresh MESC media. mESCs were added to one or more Matrigel-containing wells of a 6well plate at a density of between 5x to 6 x 105 cells/well.
2. Generation of Three-Dimensional Retinal Tissue
For this study, we utilized a mouse embryonic stem cell line consisting of a GFP
reporter knock-in at the Rax locus. The Rax gene is expressed in retinal stem cells. The
mESC with a GFP reporter at the Rx locus were cultured until approximately 70%
confluent. Cells were dissociated with 1X trypsin and neutralized with FBS containing
media. Cells were transferred into a 15mL conical tube and centrifuged for three minutes
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at 270xg. The media was removed, and the pellet was resuspended in 1mL of Glasgow
Minimum Essential Medium (GMEM). The resuspended cells (10µL) were counted using
the Countess II (Life Technologies, Carlsbad, CA).
A total of 1.28x106 cells were seeded onto a 2% agarose gel microwell mold
(MicroTissues, Inc., Providence, RI) to seed approximately 5,000 cells per microwell.
The seeded cells were placed in an incubator at 37°C under 5% CO for 24 hours. The
2

next day, the formed spheroids were centrifuged at 47xg for 1 minute to transfer the
newly formed spheroids onto a low attachment cell culture dish (Corning) using a 1%
Cultrex BME Solution (Trevigen, Gaithersburg, MD) solution in Retinal Differentiation
Media containing GMEM, 1.5% Knockout Serum Replacement (KSR), and Wnt pathway
inhibitor IWR1. On the seventh day, the media was changed to Retinal Maturation Media
containing DMEM, B27 Supplement, N2 Supplement, and bovine serum albumin (BSA),
and incubated at 37°C with 5% CO and 40% O The organoids were placed on Retinal
2

2.

Maturation Media as well as 0.3µM EC23 on days 10 to 14. The cells were checked daily
for morphological changes, and media was changed (Retinal Maturation Media) on days
14, 17, 20, 23, and 26 to ensure the cells received sufficient nutrients.
3. Generation of Lentiviral CRISPR Plasmid
We used the LentiCRISPR v2 plasmid which was purchased from Addgene
(Addgene, cat 52961). The lentiviral CRISPR plasmid envelope used was pMD2.G
vesicular stomatitis virus-G (VSV-G) expressing vector (AddGene, cat 12259), and the
packaging plasmid used was psPAX2 (AddGene, cat 12260).
3.1 Digestion and Dephosphorylation of the Lentiviral CRISPR Plasmid:
Five µg of the lentiviral CRISPR plasmid (LentiCRISPR v2) was digested and
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dephosphorylated using Esp3I Fast Digest Enzyme (Fermentas, Waltham, MA),
FastAP (Fermentas), 10X Fast Digest Green Buffer, 100mM DTT, and doubledistilled water. The plasmid was then incubated at 37°C for 30 minutes. Following
incubation, the digested and dephosphorylated plasmid was loaded onto a 0.7% low
melting agarose gel (IBI Scientific, Peosta, IA). The gel was electrophoresed at 80
volts for one hour with the electrophoresis chamber (Bio Rad, Hercules, CA) set on
ice. Following electrophoresis, the expected 10kb band containing the digested
plasmid was excised, leaving the 2kb spacer behind.
3.2 Purification of the Digested Plasmid:
The digested plasmid was purified using the QIAquick II Gel Extraction Kit
(QIAGEN, Germantown, MD). To stabilize the agarose and bind DNA, QX1 buffer,
diethylpyrocarbonate water, and QIAEX II were added and incubated at 50°C for 10
minutes. Agarose contaminants were washed using QX1 Buffer. Residual salt
contaminants were washed away using wash (PE) Buffer. DNA was eluted using
DEPC-water and quantified using a spectrophotometer (ThermoFisher, Waltham,
MA).
3.3 Phosphorylation, Annealing, Dilution, and Ligation of Oligos:
The gRNA oligos we designed were based on sequences in exon 4 of the Crx gene.
Each pair of 100µM oligos was phosphorylated and annealed using 10X T4 Ligation
Buffer (New England Biolabs, Ipswich, MA), T4 PNK (NEB), and double distilled
water. The oligo samples were placed in a thermocycler and run at 37°C for 30min,
95°C for 5 min, and finally 25°C at 0.1°C/sec. Each annealed and phosphorylated
oligo was diluted 1:500 in DEPC-water. The gRNA oligos were ligated using 50ng of
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the purified and digested plasmid, the annealed and phosphorylated oligo, T4 DNA
Ligase Buffer, T4 DNA Ligase, and DEPC water. The ligations were incubated for
120 minutes at 23°C.
3.4 Transformation of E. coli with Plasmid:
One Shot® Stbl3™ Chemically Competent E. coli (ThermoFisher) cells were
transformed with the recombinant plasmids. One vial of One Shot was thawed on ice
for each plasmid. Approximately 100ng of plasmid DNA was added to a vial and
incubated on ice for 30 minutes. The vials were transferred to a 42° water bath for 45
seconds and quickly transferred back on ice for an additional 2 minutes. SOC medium
(ThermoFisher) was added to each vial, and the total contents were then transferred to
separate test tubes. Each tube was placed in a shaking incubator at 37°C at 225rpm
for 1 hour. Samples from each tube were used to inoculate Lysogeny Broth (LB) agar
plates containing 100µg/mL ampicillin and placed in a 37°C incubator overnight. The
next day, single colonies were picked and placed in test tubes containing LB with
100µg/mL ampicillin. The tubes were then placed in a shaking incubator at 37°C,
225rpm. Once LB appeared turbid, the samples were mixed with equal amounts of
glycerol and stored at -80°C.
4. Generation of Lentiviral Particles
Human embryonic kidney (HEK) cells were cultured in a 10cm dish using high
glucose DMEM (Corning) and FBS until they reached approximately 90% confluency.
Transfection reagents were prepared using calcium chloride and DEPC-water. The
plasmid mix was made using 10µg target plasmid (CRX), 6.5µg psPAX2 plasmid, and
3.5µg of vesicular stomatitis virus-G (VSV-G) plasmid. HBS (pH 7.1) was added
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dropwise and vortexed. The mix was finally added to cultured HEK cells following a 20minute incubation at room temperature. The next day, the HEK media was removed, cells
were rinsed once with Hank’s Balanced Salt Solution (HBSS), and viral collection media
was added to the cells. The viral collection media was collected in a 50mL conical tube
(Gene Mate) after 24 hours for a total of two collections in 48 hours. The viral containing
medium was filtered using a Steriflip-HV Filter Unit, pore size 0.45µm (Millipore,
Billerica, MA).
5. Viral Infection and Generation of CRISPR Knock-down ESC Lines
Virus-containing mouse embryonic stem cell media was made using the viruscontaining collection media, FBS, non-essential amino acids, 0.1M β-mercaptoethanol,
penicillin/streptomycin, CHIR99021, and PD0325901. LIF was also added to prevent
differentiation. The media was added to mESCs when they were at approximately 90%
confluency. The mESCs were introduced to fresh virus-containing MES media for two
days, with media changes every day. On the third and fourth days, a fresh solution of
mouse embryonic stem cell media with 1µg/mL solution of puromycin was added to the
cells to eliminate all cells not infected with the virus.
6. Immunostaining
Cells were harvested in 1.7mL microcentrifuge tubes (GeneMate) upon formation
of optic cups. The cells were centrifuged at 270xg for 3 minutes, and all media was
removed. The cells were resuspended and fixed in 4% paraformaldehyde (PFA; Electron
Microscopy Sciences, Hatfield, PA), and incubated on a shaker set at 200rpm at room
temperature for 45 minutes. Following incubation, the PFA was removed, and cells were
washed with 1X PBS buffer three times. The cells were resuspended in 15% sucrose
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(Sigma-Aldridge, St. Louis, MO) and incubated for 5 hours at 4°C. The cells were
transferred to 30% sucrose overnight at 4°C. The next day, the cells were embedded onto
a cryosectioning mold with Clear Frozen Section Compound (VWR, Radnor, PA) and
kept at -80°C. All tissue sectioning work was performed with the cryostat (Leica, Buffalo
Grove, IL). The molds containing retinal tissue were transferred to sectioning chucks and
sectioned in 10-12µm slices. The sections were then transferred to micro-slides (VWR).
The slides were washed three times with 1X PBS containing 0.1% Triton (SigmaAldridge) at 5 minute intervals. Following the rinses, 1X Donkey serum (SigmaAldridge) was added and incubated in a humid chamber at 4°C for one hour. Following
incubation, the serum was washed off once with 1X PBS containing 0.1% Triton. The
primary antibody (Table 2) was added, and the slides were kept in a humid chamber at
4°C overnight. The following day, the slides were washed 5 times with 1X PBS
containing 0.1% Triton. The secondary antibody was added, and the slides were
incubated in a humid chamber at 4°C for one hour. Following incubation, DAPI was
added. The slides were finally rinsed 5 times with 1X PBS containing 0.1% Triton and
mounted with Fluoromount mounting media (Electron Microscopy Sciences). The slides
were screened for morphological changes on the confocal microscope ZEISS Imager M.2
(ZEISS, Pleasanton, CA).
7. RNA Extraction and QRT-PCR Analysis for Retinal Genes
Total RNA was extracted into 1.7mL microcentrifuge tubes (Gene Mate) using
TRIzol (Sigma-Aldridge). The extracted RNA was purified using the Direct-Zol Mini
Prep Kit (Zymo, Irvine, CA). A 1:1 volume of 100% ethanol (Fisher Scientific, Waltham,
MA) was added to the RNA in TRIzol and vortexed. The sample was then loaded on to a
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Zymo-Spin IIC column in a collection tube (Zymo) and centrifuged at 16,000xg for one
minute. The column was transferred to a new collection tube, Direct-Zol RNA Prewash
was added, and the column was centrifuged at 16,000xg one minute. RNA wash buffer
was added to the column and centrifuged at 16,000xg for one minute. The column was
finally transferred into a 1.7mL micro-centrifuge tube, 50µL of nuclease-free water was
added directly to the column matrix, and the tube was centrifuged at 16,000xg to elute the
RNA. RNA was stored at -80°C.
Complementary DNA (cDNA) for quantitative RT-PCR (qRT-PCR) was
synthesized using the iScript cDNA Synthesis Kit (Bio-Rad) following manufacturer’s
instructions. Briefly, 500ng of the purified RNA template, 4µL of 5X iScript Reaction
Mix, 1µL of iScript Reverse Transcriptase, and DEPC-water were combined and
incubated in a thermal cycler as follows: 5 minutes at 25°C, 30 minutes at 42°C, and 5
minutes at 85°C. Following cDNA synthesis, qRT-PCR was performed using forward
and reverse primers designed for target genes (see Appendix Table 1) in a 96-well PCR
plate (Bio-Rad).
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RESULTS
1. Generation of a Novel Three-Dimensional Retinal Differentiation Protocol
1.1 Initial Counting and Seeding of Mouse ES Cells into Microwell Culture
Molds
Prior studies have shown that cell count dictates retinal induction during
differentiation of mouse ES cells (Eiraku, 2012; Volkner, 2016). Therefore, for our initial
cell seeding step, it was important for us to have an accurate cell count. We utilized both
manual and automatic cell counting techniques. For manual cell counting we used a
hemocytometer (Figure 6A), and for automatic cell counting we utilized the Countess II
by Life Technologies (Figure 6B). Both techniques required 10µL of cell solution. We
were able to obtain a similar concentration of cells per milliliter of solution using both

Figure 6: Optimization of Cell Counting Prior to Seeding of Mouse Embryonic Stem Cells. (A) Manual
Hemocytometer (B) Automatic Cell Counter Countess II by Life Technologies. (C) Bright field image of
resuspended cells in the chamber of Countess II. (D) Screenshot of cells that were counted using Countess II.
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methods, although the Countess II was quicker. Figure 6C shows a bright field image of
cells in the Countess II cell counter. Figure 6D depicts the screen of the Countess II
following cell counting. Countess II calculates live cells versus dead cells as an actual
number and as a percentage.
Mouse ES cells were initially seeded into agarose gel microwell cell culture dishes
in Retinal Induction Media (Figure 7A). Around 24 hours post seeding, we observed
proper aggregation of cells. The cells exhibited proper spheroid formation in the agarose
gel mold at day 1 (Figure 7B).

Figure 7: Initial Seeding of Mouse ES Cells. (A) Initial seeding of mouse ES cells into the agarose gel microwell cell
culture dish at day 0. (B) Bright field image showing aggregate formation of mouse ES cells in the agarose microwell
cell culture dish 24 hours. Scale bar 450µm.

In order to determine which cell seeding density resulted in better retinal
induction, we differentiated mouse ES cells with an initial seeding density of 1,500
cells/well and 3,000 cells/well. At seven days post differentiation, we extracted total
RNA from the organoids and performed qRT-PCR. We found that when compared to
undifferentiated mouse ES cells, retinal and photoreceptor precursor genes Lhx2 and
Otx2, respectively, had higher expression levels in organoids with an initial seeding of
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1,500 cells as opposed to organoids with an initial seeding of 3,000 cells (Figure 8).
Expression of photoreceptor precursor gene, Otx2, was upregulated nearly 87-fold in

Figure 8: Initial Seeding of 1,500 Cells per Microwell Results in Increased Retinal Expression at Day 7. qRT-PCR data
shows increased expression of retinal precursor genes (Lhx2, Rax, and Otx2) as well as late photoreceptor genes (Thrb
and Prdm1) compared to undifferentiated mouse ES cells. All samples normalized to mouse B-actin.

organoids with an initial seeding density of 1,500 cells/well compared to undifferentiated
mouse ES cells, whereas Otx2 was upregulated by only ~51-fold in organoids with an
initial cell seeding density of 3,000cells/well. We also observed that Lhx2, a retinal
precursor gene, was upregulated by 40-fold in organoids with an initial seeding density of
1,500 cells/well compared to a 13-fold expression in cells with an initial seeding density
of 3,000 cells/well. Another striking observation was the presence of Rax, a retinal stem
cell precursor gene. At day 7, Rax was upregulated by nearly 14-fold in organoids with
an initial seeding density of 1,500 cells/well when compared to undifferentiated mouse
ES cells. Late photoreceptor marker Thrb is upregulated by 3-fold in organoids with an
initial seeding of 1,500 cells, and 6-fold in organoids with an initial seeding of 3,000
cells. Another late photoreceptor marker, Prdm1, is not much upregulated at 7 days, as
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normally expected.
A consistent problem with every differentiation included the number of dead cells
that accumulated following the day 7 media transition. We first used maturation media
containing Dulbecco’s Minimum Essential Media (DMEM) with no Fetal Bovine Serum
(FBS), then transitioned into another maturation media which contained DMEM as well
as 10% FBS at day 10 (Hiler, 2016). At first, we suspected the change into retinal
maturation media with no FBS at day 7 was too harsh of a shift. This hypothesis was
backed by the idea that the amount of nutrients of serum replacer found in the induction
media was dramatically reduced following the media change. The change in media did
not meet the nutrient requirement of developing retinal cells, which caused them to die.
We then transitioned into using DMEM media containing 10% FBS from day 7 onwards
instead of day 10. We found that this only caused cells to divide rapidly, resulting in the
loss of the evaginated edges found in developing retinal organoids, and the presence of
large masses of organoids consisting of both dead and live cells. We finally moved on to
another maturation media, which included Neurobasal media with B27 supplement,
Bovine Serum Albumin (BSA), and N2 supplement. All of the supplements used in
conjunction with BSA allowed us to see a dramatic reduction of cell death at day 7, and a
continued growth and maturation of retinal organoids.
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1.2 Modulation of Molecular Pathways to Induce Retinal Development
We also wanted to test whether the modulation of a certain pathway involved in
retinal development would result in an increased expression of retinal genes (Figure 9).
Modulation of the Wnt pathway is known to drive anterior neural plate formation

Figure 9: The use of Wnt Modulator, IWR1, in Conjunction with Matrigel Increases Expression of Retinal Genes at
Day 7. qRT-PCR data shows an increase in photoreceptor precursor gene Rax in organoids treated with IWR1, a Wnt
inhibitor when compared to undifferentiated mouse ES cells. All samples were normalized to B-actin.

(Nakano, 2012; Fujimura, 2016). On day 1 of differentiation, we treated organoids with
2µM of Wnt inhibitor IWR1 for 48 hours either with or without Matrigel. We continued
culturing the organoids, collected total RNA on day 7, and measured gene expression
using qRT-PCR. We found that a 48-hour treatment of organoids treated with 2µM IWR1
combined with 2% Matrigel resulted in a 102-fold increase in Lhx2 and a 142-fold
increase in Otx2 expression compared to undifferentiated mouse ES cells. We also found
that Rax, a photoreceptor precursor, was also upregulated nearly 117-fold at day 7.
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Conversely, the absence of Matrigel resulted in a 94-fold increase in Otx2 expression
compared to undifferentiated mouse ES cells. Though no other significant expression
level differences were observed in organoids with an absence of Matrigel, we concluded
that the presence of Matrigel in conjunction with IWR1 is necessary for retinal induction.
1.3 Final Retinal Induction Protocol

Figure 10: Retinal Development Timeline. Cells are initially seeded at Day 0. From Day 0 to Day 7, retinal clusters
are cultured in Retinal Induction Media. A 2% matrigel solution is added on Day 1. 2µM of Wnt-modulator IWR1 is
administered on Day 1, and is removed from the media on Day 3. The organoids are transitioned to Retinal Maturation
Media on Day 7 until Day 28. Synthetic retinoid analogue EC23 is administered on Day 10, and is removed from the
culture media on Day 14.

Our final retinal induction timeline begins on day 0 and ends on day 28 (Figure 10).
Day 0 is the initial mouse ES cell seeding, wherein 5,000 cells are seeded per microwell
of a gel microwell cell culture mold. Following aggregate formation of these cells in the
gel microwell cell culture mold on day 1, the formed spheroids, or retinal organoids, are
transferred into ultra-low attachment culture dishes. At this stage, 2% Matrigel solution is
administered into the cell culture media at day 1. The retinal organoids are cultured in a
Retinal Induction Media between day 0 and day 7, which includes Glasgow’s Minimum
Essential Media and 1.5% Knockout Serum Replacer (KSR). From day 7 until day 28,
the retinal organoids are cultured in a Retinal Maturation Media, which includes
Dulbecco’s Minimum Essential Media, B27 supplement, Bovine Serum Albumin (BSA),
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and N2 Supplement. A 0.3µM EC23 treatment of the retinoids between days 10 and 14 is
administered to promote proper lamination of photoreceptors.

Figure 11: Bright-field Images Depicting Retinal Development. (A) Day 2 organoids exhibit semi apparent lamination
along outer edge. (B) Day 4 organoids show proper lamination around outer edge of organoid. (C) By day 7,
evaginations from the outer edge appear. (D) Retina-like structures visible at outpouching areas. (E)Day 16 organoids
exhibit a fully stratified retina. Scale bars 100µm.

To keep track of morphological changes in organoids, bright-field images were
taken using the 4X objective magnification at various time points (Figure 11). At day 2
post seeding, the organoids exhibit a laminated outer edge, which remains consistent
throughout all retinal induction stages (Fig 11A). By day 4, the retinas show proper
lamination across the outer edge of the organoid (Fig 11B). Evaginations around the
laminar edges are expected to appear around day 7 (Fig 11C) and continue to expand into
maturing retinas (Fig 11D). By day 16, a fully developed retina is seen, exhibiting all
morphological characteristics as in vitro retinal organoids (Fig 11E) (Volkner, 2016).
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2. Optimizing Maturation of Retinoids: Retinoid Analogues Promote Photoreceptor
Lamination

Figure 12: Synthetic Retinoid Analogues Result in Similar Photoreceptor Lamination as Natural Retinoids. (A’, B’, C’)
Pan-photoreceptor marker Recoverin is expressed in retinal cells, however proper lamination is lacking in organoids
not treated with retinoids. (A’’, B’’, C’’) Mature rod opsin, Ret-P1, expression remains consistent across all
conditions. Arrowheads show areas where proper photoreceptor lamination is either absent (A’) or is present (B’, C’).
DAPI stains nuclei. Scale bars 50µm.

Following retinal fate induction, we focused our efforts on methodologies to
promote photoreceptor development and lamination in our cultures. Previous studies have
suggested that the use of retinoid analogues assist in the lamination of photoreceptors in
vitro cultures (Zhao, 2006; Eiraku, 2012). We wanted to confirm whether the use of
retinoids (natural and synthetic) assisted in a proper lamination of maturing photoreceptor
cells in our system. We administered either 0.5µM of an all-trans Retinoic Acid (ATRA),
a natural retinoid analogue, or 0.3µM EC23, a synthetic retinoid analogue, to the
organoids from day 10 to day 14. The organoids were then fixed with 4% PFA on day 28,
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and immunohistochemistry was performed. Using the pan-photoreceptor marker
recoverin (Rec) and the rod photoreceptor opsin marker rhodopsin (Ret-P1), we
determined that there were similar photoreceptor lamination patterns in organoids treated
with either ATRA or EC23. As expected, organoids not treated with retinoids lacked
proper lamination of photoreceptor cells, as shown in Figure 12A-12A’’’. The recoverin
marker indicates that in untreated organoids photoreceptor cells are scattered throughout
the organoid, as opposed to exhibiting a proper laminated edge (Fig 12A’). However,
organoids that were treated with ATRA exhibited a proper lamination in the outer edge,
with most photoreceptor cells residing along the outer edge (Fig 12B-12B’’’). A similar
expression pattern was noted among organoids treated with synthetic retinoid analogue
EC23 (Fig 12C-12C’’’).
3. Three-Dimensional Retinal Development Following CRISPR Knockdown of Crx
3.1 Generation of Guide RNA (gRNA) for CRISPR Knockdown of Crx
As previously stated, Crx is a homeobox gene that is essential for the production of
photoreceptor cells in the presence of its coactivator, Otx2 (Ohsawa, 2007). We first
designed gRNAs with the promotor sequence targeting exon 1 of the Crx gene. Following
generation and differentiation of the mouse ES cell CRISPR knockdown lines, we saw
that photoreceptor expression remained consistent between both the control line with no
knockdown, as well as the knockdown lines. There are a total of two known spliced
variants of the Crx gene in Mus musculus. With the first set of gRNAs we designed, we
found that we were only targeting the first isoform, and the Crx gene was still being
expressed, and in turn, the protein was still being produced with the second isoform of
the gene still remaining fully functional. We then redesigned and optimized our gRNAs
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with the protospacer sequence of the gRNA targeting both isoforms of Crx. Exon 4, being
included in both isoforms, was the ideal target region for gRNAs.
The Crx knockdown lines were generated following Lentiviral infection of mouse
ES cells with plasmids containing gRNA (P1 and P24) targeted at specific sites of Crx
exon 4 (Figure 13). We then co-infected mouse ES cells with Lentivirus containing the
P1 and P24 plasmids (Figure 14). By doing so, we hoped to either generate two

Figure 13: Target Regions of Expected Crx Knockdowns on Exon 4. gRNA “P1” was designed to target the 12,452-12,474
base-pair region of Crx exon 4. gRNA “P24” was designed to target the 12,144-12,166 base-pair region of Crx exon 4.

individual single nucleotide polymorphisms (SNPs) (Figure 14), or completely excise an
with the protospacer sequence of the gRNA targeting both isoforms of Crx. Exon 4, being
included in both isoforms, was the ideal target region for gRNAs.
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Figure 14: Proposed CRISPR-mediated Crx Knockdown Schematic 1. With the co-infection of mouse ES cells with
CRISPR lentivirus containing gRNA targeting both P1 and P24, respectively, we propose that we can excise the
approximate 300 base-pair region located in between the P1 and P24 region. The reannealing of the target strands
would result in altered or hindered Crx protein function.

The Crx knockdown lines were generated following Lentiviral infection of mouse
ES cells with plasmids containing gRNA (P1 and P24) targeted at specific sites of Crx
exon 4 (Figure 13). We then co-infected mouse ES cells with Lentivirus containing the
P1 and P24 plasmids (Figure 14). By doing so, we hoped to either generate two
individual single nucleotide polymorphisms (SNPs) (Figure 14), or completely excise an
approximate 300bp region in between the nick sites (Figure 15), resulting in a
nonfunctional Crx protein. Mouse ES cells that were successfully infected with the
CRISPR plasmid were selected by being cultured in the presence of puromycin. Three
healthy clones (Clones A, B, and C) were isolated and cultured. We then differentiated
the mouse ES clones to analyze both gene and protein expression.
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Figure 15: Proposed CRISPR-mediated Crx Knockdown Schematic 2. Proposal 2 involves the co-infection of mouse ES
cells with CRISPR lentivirus containing gRNA targeting both P1 and P24, respectively. We propose that by doing so,
we can induce two individual SNPs resulting in two point mutations. The outcome can result in either an altered or
hindered Crx protein function.
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3.2 CRISPR Crx-Knockdown Mouse ES Cell Lines Exhibit Hindered
Photoreceptor Development

Differentiation of mESC lines with a functional Crx gene as well as the Crx
knockdown lines, Clones A through C, into three-dimensional retinas was attempted.
Unfortunately, Clone B failed to differentiate. At day 21, total RNA was extracted from

Figure 16: Decreased Photoreceptor Development Following CRISPR Knockdown of Crx P1/P24 at Day 21.
Compared to Day 28 organoids with no knockdown, pan-photoreceptor gene Recoverin, as well as all mature
photoreceptor genes (S-Opsin, Rhodopsin, Cone/Arr3) were downregulated in Day 28 knockdown organoids. All
samples were normalized to B-actin.

differentiated Crx knockdown organoids (Clone A and Clone C), and gene expression
levels were quantified using qRT-PCR. We found that photoreceptor genes (Recoverin,
S-Opsin, Rhodopsin, and Cone/Arrestin 3) were down-regulated compared to organoids
with no knockdowns (Figure 16). Recoverin was down-regulated 2-fold in both clones
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compared to control. An interesting observation was S-Opsin expression in Crx
Knockdown Clone C, which was downregulated nearly 20-fold compared to organoids
with no knockdowns. Rhodopsin expression was down-regulated in both clones.
Cone/Arrestin3 was also downregulated 5-fold in both clones. This confirmed to us that
the expression of the photoreceptor genes located downstream of Crx was hindered in our
knockdown lines.
To determine if expression of photoreceptor proteins were likewise down-regulated
in the Crx knockdown lines, immunohistochemistry was carried out on mature threedimensional retinas. Otx2 is a gene that is found upstream of the photoreceptor
developmental pathway. We found that, as expected, there was a significant number of
cells expressing Otx2 in the control with no knockdown (Fig 17A-3C). A zoomed in
region of this organoid shows Otx2 expression patterns in more detail (Fig 17A’-17C’).
We also found that there was no difference in Otx2 expression between both knockdown
lines, clone C (Fig 17D-17F) and clone A (Fig 17G-17I), compared to organoids without
knockdowns (Fig 17A-17C). Zoomed in regions of Crx knockdown Clone C (Fig 17D’17F’) and Crx knockdown Clone A (Fig 17G’-17F’) show Otx2 expression in detail.
3.3 CRISPR Crx-Knockdown Mouse ES Cell Lines Exhibit Hindered
Photoreceptor Development

Differentiation of mESC lines with a functional Crx gene as well as the Crx
knockdown lines, Clones A through C, into three-dimensional retinas was attempted.
Unfortunately, Clone B failed to differentiate. At day 21, total RNA was extracted from
differentiated Crx knockdown organoids (Clone A and Clone C), and gene expression
levels were quantified using qRT-PCR. We found that photoreceptor genes (Recoverin,
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S-Opsin, Rhodopsin, and Cone/Arrestin 3) were down-regulated compared to organoids
with no knockdowns (Figure 16). Recoverin was down-regulated 2-fold in both clones
compared to control. An interesting observation was S-Opsin expression in Crx
Knockdown Clone C, which was downregulated nearly 20-fold compared to organoids
with no knockdowns. Rhodopsin expression was down-regulated in both clones.
Cone/Arrestin3 was also downregulated 5-fold in both clones. This confirmed to us that
the expression of the photoreceptor genes located downstream of Crx was hindered in our
knockdown lines.
To determine if expression of photoreceptor proteins were likewise down-regulated
in the Crx knockdown lines, immunohistochemistry was carried out on mature threedimensional retinas. Otx2 is a gene that is found upstream of the photoreceptor
developmental pathway. We found that, as expected, there was a significant number of
cells expressing Otx2 in the control with no knockdown (Fig 17A-3C). A zoomed in
region of this organoid shows Otx2 expression patterns in more detail (Fig 17A’-17C’).
We also found that there was no difference in Otx2 expression between both knockdown
lines, clone C (Fig 17D-17F) and clone A (Fig 17G-17I), compared to organoids without
knockdowns (Fig 17A-17C). Zoomed in regions of Crx knockdown Clone C (Fig 17D’17F’) and Crx knockdown Clone A (Fig 17G’-17F’) show Otx2 expression in detail.
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Figure 17: Expression of Genes Located Upstream of Crx in the Developmental
Pathway Remain Unaltered at Day 28. (A-C) Day 28 Control organoids were stained
with OTX2, an upstream cofactor. (D-I) Day 28 knockdown organoids exhibit similar
OTX2 expression as control. DAPI stains nuclei. Scale bars 50µm.
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Following confirmation that Crx knockdown organoids express early retinal
markers, we wanted to observe if there was a decrease in protein production downstream
of Crx expression. On day 28, after three-dimensional retinal differentiation,
immunohistochemistry was used to detect expression of the pan-photoreceptor marker
Recoverin and opsin marker Ret-P1. As shown in Fig 18A to Fig 18D, we found that our
control line consisted of an abundance of cells expressing both Recoverin and Ret-P1
(Fig 18B and Fig 18C). In both Crx knockdown clones, however, there were fewer cells
expressing Recoverin (Fig 18F and Fig 18J). There were also fewer cells expressing rod
opsin marker Ret-P1 compared to control (Fig18C and Fig 18K).
Currently, our lab is in the process of genotyping the knockdown lines to determine
whether the 300 base-pair region is truly excised or if point mutations have been induced.
In efforts to clarify the PCR results, PCR primers have been designed, targeting both the
P1 and P24 regions independently. These primers may allow us to visualize point
mutations at both sites.
In addition to optimizing PCR primers, we have also started optimizing protocols
for genotyping CRISPR knockdowns. A recent study suggests the use of polyacrylamide
gel electrophoresis (PAGE) as opposed to traditional agarose gel electrophoresis result in
better image quality of bands when genotyping CRISPR generated cells (Zhu, 2014). The
study suggests that PAGE assays are able to detect a variety of indel mutations generated
via nuclease systems such as CRISPR/Cas9 with high efficiency, regardless of
sensitivity. We will validate the efficiency of genotyping with PAGE versus agarose gel
electrophoresis in our knockdown mouse ES cell lines.
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In addition to using PAGE assays, we also plan to utilize specific techniques
developed for detecting point mutations. A recent study suggests that the SURVEYOR
nuclease assay is efficient in detecting indels and specific point mutations in CRISPR
knockdown cell lines (Ran, 2013). We will utilize this nuclease assay to confirm whether
we were able to induce point mutations.
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Figure 18: Crx P1/P24 Knockdown Clones Show Restricted Photoreceptor Development. (B, F, J) Day 28
knockdown clones show lack of proper lamination of photoreceptor cells, as shown by pan-photoreceptor
marker Recoverin when compared to control organoids with no knockdown. (C, G, K) In addition, there was
limited expression of mature rod opsin protein, Ret-P1, in both knockdown lines compared to control DAPI
stains nuclei. Scale bars 50µm.
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DISCUSSION

As indicated by the results, we have been successful at developing a protocol for
differentiating mouse embryonic stem cells into three-dimensional retinas in vitro. When
developing our three-dimensional protocol, we first considered all limitations of currently
published protocols (Decembrini, 2014; Eiraku, 2012; Hiler, 2016; Volkner, 2016). The
first limitation was the use of low attachment 96-well plates. According to all threedimensional retinal differentiation studies conducted by Eiraku (2012), the use of 96-well
low attachment culture plates at the initial seeding step resulted in proper aggregate
formation of cells, leading to the proper development of a three-dimensional neural
retina. However, we found this to be a limitation for our differentiating protocol for
several technical reasons, all of which affected output efficiency. Theoretically, we
should expect a maximum output of 96 spheroids from a 96-well plate. However, the
rinsing steps in our protocol had a tendency to remove the coating from the wells, causing
the newly seeded cells to stick to the outer walls of the wells and not cluster at the bottom
of the wells as aggregates. In addition, it was quite labor intensive to individually seed
cells into all 96-wells of the plate. Finally, transferring the formed aggregates onto low
attachment culture plates without disrupting or damaging the spheroid involved
meticulous and gentle flushing of the spheroids out of each individual well. Not only time
consuming, this method could not guarantee that all spheroids would remain undamaged
by the end of the procedure.
In our revised protocol, we found agarose gel culture dishes to be more efficient
compared to traditional 96-well plates for initial aggregate formation. It is a more cost-
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effective method, and cells are simply seeded directly onto the mold, whereupon the cells
naturally gravitate into each of the 256 individual wells of the culture dish. Another
benefit to these culture dishes is the fact that the transfer of the formed aggregates as
floaters onto low attachment culture dishes is gentler on the organoids than traditional
flushing. One drawback to using these agarose gel dishes is that we cannot control the
movement of each individual cell into a designated well. Once the cells are seeded, they
migrate to their well of choice, resulting in inconsistent number of cells in each well. One
way we have overcome the inconsistency in exact cell count is to measure the diameter of
each organoid at 24 hours’ post seeding. Prior studies have shown that in terms of mouse
ES cells, an approximate organoid diameter of 450µm at 24 hours is equivalent to 1,500
cells per organoid (Volkner, 2016). In our case, organoids consistently developed with a
diameter of 450µm at 24 hours.
Our results also confirm that the developing retina has specific requirements for
both the retinal induction and retinal maturation cell culture media. When developing the
three-dimensional retinal differentiation protocol, we wanted to be sure that the base
media was void of any unknown protein or lipid that could influence or bias the mouse
ES cells towards a retinal fate. Thus, Glasgow’s Minimum Essential Media (GMEM) was
selected as a base media for our initial retinal induction steps. Along with using GMEM,
we also used components similar to those in previously published journals including
Knockout Serum Replacer (KSR) and 2-β Mercaptoethanol (BME) (Decembrini, 2014;
Eiraku, 2012; Hiler, 2016; Volkner, 2016).
According to a previous study by Volkner (2016), the number of cells used in the
initial seeding affects retinal differentiation. In one study, we observed that a lower initial
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seeded density of mouse ES cells resulted in the presence of more retinas compared to a
larger initial seeding density (Volkner, 2016). Contrary to this study, we found that
organoids with a higher number of cells at initial seeding exhibited an increased
expression of early retinal precursor genes when compared to organoids with a lower
number of cells at initial seeding. Mouse ES cells that formed any spheroid measuring
less than or equal to approximately 450µm in diameter on day 1 resulted in palpitating
organoids when differentiating under the same conditions as their counterparts. We can
conclude that a dense network of cells is initially required to drive mouse ES cells to a
retinal fate.
Prior studies have also claimed that cutting each organoid during differentiation
has resulted in more retinal embryoid bodies than organoids that were not cut (Nakano,
2012; Volkner, 2016). However, we found that cutting organoids resulted in massive cell
death. Although cutting the organoids at later time points was then attempted, high cell
death continued to occur, which demonstrated that in our system, cutting organoids do
not help with the optimal growth of retinal organoids.
Multiple studies have shown that in two-dimensional differentiation of stem cells,
the modulation of certain pathways in the presence of small molecule inhibitors have the
ability to bias cell fate (De Longh, 2006; Perrimon, 2012; Fujimura, 2016). In our study,
mouse ES cells were differentiated using a small molecule inhibitor targeting the Wnt
pathway. Prior studies have shown than modulating the Wnt pathway during ES cell
differentiation promotes neural induction of the retina (Liu, 2006; Liu, 2010; Sakakura,
2016; Fujimura, 2016). Consistent with these studies, we found that a small molecule
inhibitor targeting just the Wnt pathway promoted retinal induction in our three-
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dimensional organoids.
Studies have shown that the use of natural retinoid analogues such as all-Trans
Retinoic Acid (ATRA) allows for a more structured layer or lamination of photoreceptors
cells (Zhao, 2006; Eiraku, 2012). However, a prolonged treatment of ATRA inhibits
differentiation and maturation of photoreceptor cells (Eiraku, 2012). Although we found
that the use of retinoids is beneficial for photoreceptor lamination during in vitro threedimensional retinogenesis, it is not known whether the addition of retinoids plays any
additional role during in vitro development. Retinoids are traditionally known to play a
role in the visual cycle. Specifically, the isomerization of retinoids in the retina allow the
initial absorption of photons entering the eye via photoreceptor cells and transfers these
light signals to the inner nuclear layer (Kiser, 2013). The importance of retinoids in vivo
vertebrate models is well studied and understood, however, current studies fail to
characterize the exact developmental cues that occur following the addition of retinoids
in vitro.
Since ATRA has some technical drawbacks—it is sensitive to light and loses
potency after multiple freeze-thaw cycles, a more robust, synthetic compound known as
EC23 was also used in our study. As shown in Figure 12, both ATRA and EC23 resulted
in laminated photoreceptor architecture. Due to its stability, EC23 was chosen over
ATRA for photoreceptor lamination in our protocol.
When first co-infecting mouse ES cells with lentivirus containing gRNAs targeting
the P1 and P24 regions, respectively, we initially hypothesized that this co-infection
would most likely result in the removal of the 300 base-pair region, which in turn would
result in the production of a nonfunctional Crx protein. As suggested by the gene
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expression analysis of day 21 Crx knockdown organoids, there was a reduction of
expression of mature photoreceptor genes including Recoverin, S-Opsin, Rhodopsin, and
Cone-Arrestin3 (Figure 16) at the transcriptional level, when compared to day 21 control
organoids. These preliminary results suggest that the induced knockdown lines have a
negative effect on genes whose expression depends on Crx. Protein expression in the Crx
knockdown lines was also analyzed. Our study confirmed that a protein expressed
upstream of Crx—Otx2 —was not affected by the knockdown of Crx (Figure 17),
whereas proteins expressed downstream of Crx— namely the pan-photoreceptor protein
Recoverin and the opsin Ret-P1— were downregulated in both knockdown lines
compared to control (Figure 18).
From this study, we can deduce that it is possible to generate three-dimensional
retinas in vitro in a high-throughput manner using embryonic stem cells. Retinal
organoids are a step towards not only improving treatments for patients with retinal
degenerative diseases, but the regenerative medicine field as a whole. Some studies have
also demonstrated that it is possible to restore some visual function in mice following
transplantation of photoreceptor cells derived from a 2D culture (Lamba, 2009; Pearson,
2012). These studies show it is possible for transplanted exogenous cells to integrate into
the host retinal tissue. However, it is not entirely feasible to generate a homogenous
quantity of cells in a two-dimensional culture system as it is in three-dimensional
organoids, especially when it comes to tissues composed of multiple cell types like the
retina. The in vitro generated retinas have the capacity of generating a homogeneous
supply of cells for transplantation purposes (Decembrini, 2014).
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Although we are still undergoing the process of confirming efficient CRISPRmediated Crx knockdown in mouse ES cells, it has been shown that the CRISPR/Cas9
system is translatable into animal models, and soon, patients (Yu, 2017). The induced
proliferation of cone photoreceptors in mice resulting from a CRISPR/Cas9 knockdown
of rod-specific gene NRL allowed for preservation of the function of cone cells (Yu,
2017). In addition, utilizing three-dimensional organoids in conjunction with
CRISPR/Cas9 shows it is possible to generate disease models in vitro (Ravi, 2015). As
previously indicated, three-dimensional models display in vivo characteristics far greatly
than two-dimensional cell cultures.
The use of CRISPR/Cas9 to study disease progression in three-dimensional
organoids can minimize the use of laboratory animals (Pampaloni, 2007). For example,
using three-dimensional models to study the progression of retinal degeneration caused
by any one of the 49 mutations in Crx is far more feasible than generating animal models
for each mutation (Huang, 2012). With our study, we hope to expand the use of threedimensional organoids to study disease progression.
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Appendix
Gene Name

Forward Primer (5’-3’)

Reverse Primer (3’-5’)

Tm °C

Β-actin

GCTCTGGCTCCTAGCACCAT

GCCACCGATCCACACAGAGT

59

GAATGCAAGCTCAACCTGG

GAGAACCGCCTGTAGTAGTC

GAAGCGGCTTTGAGAAGTG

ATTCTCAGATCCCTGTGAGC

CTTCGAGAAGTCCCACTACC

CTGGAACCATACCTGGACC

CAATGCGGCTGTAAGTTCC

GGCGGTTGCTTTAGATAAGAC

Recoverin

GCAGCTTCGATGCCAACAG

TCATGTGCAGAGCAATCACGTA

57

Rhodopsin

TCAAGCCTGAGGTCAACAAGC

ACTTCCTTCTCTGCCTTCTGAGTC

58

GGAGTCCTTGACCATGACC

54

Lhx2
Pax6
Rax
Otx2

GTTTATCTGGTGTGAAGACTGC

Prdm1

AGGACGACTCCATCAATGG

54
54
54
54

Cone/Arrestin
3

CAGTGTTTAAGAAGACTAGCTCC

Thrb

ATGTCTTCAGATCGCCCAG

GTGTTCAAAGGCCAACAGG

54

S-Opsin

CAGCATCCGCTTCAACTCCAA

GCAGATGAGGGAAAGAGGAATGA

57

Table 1: List of Primers used for qRT-PCR

Antigen

Host

Catalog Number

RECOVERIN

Rabbit

AB5585

RET-P1

Mouse

O4886

OTX2

Goat

BAF1979

CRX
Rabbit
ab140603
BCO
Goat
14363
Table 2: List of Antibodies used for Immunohistochemistry
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Supplier
EMD
Millipore
Sigma
Aldridge
R&D
Biosystems
Abcam
Santa Cruz

Dilution
1:100
1:500
1:500
1:250
1:250
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Primer
Name
Crx
Primer
1a
Crx
Primer
1b
Crx
Primer
2a
Crx
Primer
2b
Crx
Primer
3a
Crx
Primer
3b
Crx
Surveyor
4a
Crx
Surveyor
4b
Crx
Surveyor
4c
Crx
Surveyor
4d
Crx
Surveyor
4e
Crx
Surveyor
4f
Crx
Surveyor
4g
Crx
Surveyor
4h

Forward Primer (5’-3’)

Reverse Primer (3’-5’)

Tm °C

Amplicon
Size (bp)

CTCAGATTCTTACAGCCCATCTC

CCAGGCACTCTGATCTTTGTAG

55

469

GTACAGATCCTTTGGGCATCTC

TTGTAGTCCAGAGGGTCCAT

55

472

TCCTCTGACTTGCTCAGTTTG

CTCATTGTCCTTCTGCCTCTAC

55

464

GAAGCAGGAGCTGATGTAGAG

GGCCTCAAACTTGCATTGTAG

55

554

TTCCTACCCTCAGCTCCTTTA

CTACCTCCCTCGTGTTGAAATC

55

1409

ATGGACCCTCTGGACTACAA

CTCATTGTCCTTCTGCCTCTAC

55

1629

CTCAGATTCTTACAGCCCATCTC

GTGATTCCGCTGGAAGGG

55

522

TTGGGCATCTCAGATTCTTAC

CCCTTCTACAAGATCTGAAACTT

55

500

TGGGCATCTCAGATTCTTACAG

GGTCCATGGGATTGTAGGTAAA

55

447

AGAGGAAGGCAGGGACAT

AGAGGAAGGCAGGGACAT

55

505

GGGTTGGATCCCTACCTTTC

CTGGAGAGATGACTCAGCAATTA

55

1737

AGTTCCTATTTCAGTGGGTTGG

GTGCCATCACTCCTGGTTTAT

55

1794

CGGCTTCTGCTTTCTGTTCTT

TTCCTGGTGTGTCTGGAGATAG

55

1683

GCTTATGCATCTCCAAGTTCCTATT

TGTGGTGGCTCACAACTATCT

55

1694

Table 3: List of Primers used for Genotyping CRISPR Knockdowns
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Symbol
Name
3D
Three-dimensional
ATRA
All-trans Retinoic Acid
BCO
Blue Cone Opsin
BME
Bismercaptoethanol
cDNA
Complementary DNA
CoDA
Context-dependent Assembly
Cone/Arr3
Cone/Arrestin 3
CRISPR
Clustered Regularly Interspersed Short Palindromic Repeats
crRNA
CRISPR RNA
Crx
Cone-rod Homeobox
DMEM
Dulbecco’s Minimum Essential Media
DNA
Deoxyribonucleic Acid
ES Cell
Embryonic Stem Cell
FBS
Fetal Bovine Serum
GCL
Ganglion Cell Layer
GMEM
Glasgow’s Minimum Essential Media
gRNA
Guide RNA
HBSS
Hank’s Balanced Salt Solution
HDR
Homology Directed Repair
INL
Inner Nuclear Layer
KSR
Knockout Serum Replacer
LIF
Leukemia Inhibitory Factor
mESC
Mouse Embryonic Stem Cell
MG
Müller Glia
NHEJ
Non-homologous End Joining
ONL
Outer Nuclear Layer
OPEN
Oligomerized Pool Engineering
Otx2
Orthodenticle Homeobox 2
PBS
Phosphate Buffered Saline
PCR
Polymerase Chain Reaction
PFA
Paraformaldehyde
qRT-PCR
Quantitative Reverse Transcriptase PCR
Rec
Recoverin
RNA
Ribonucleic Acid
RPE
Retinal Pigment Epithelium
sgRNA
Single Guide RNA
SNP
Single Nucleotide Polymorphism
TALENs
Transcription Activator-like Effector Nuclease
trRNA
Tracr RNA
Wnt
wingless-type MMTV (mouse mammary tumor virus) integration site
ZFN
Zinc Finger Nuclease
Table 4: Table of Abbreviations
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